An Open-label Study Assessing Effectiveness, Safety and Compliance With Fexinidazole in Patients With Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Latest Information Update: 10 Jun 2024
At a glance
- Drugs Fexinidazole (Primary)
- Indications Trypanosomiasis
- Focus Therapeutic Use
- 07 Jul 2023 Interventional Study Model has been change to Parallel, number of treatment arms changed to 2.
- 08 Oct 2021 Status changed from active, no longer recruiting to completed.
- 19 Dec 2019 Status changed from recruiting to active, no longer recruiting.